At the 2024 ARVO meeting, there were a number of groundbreaking myopia posters and papers. Review of Myopia Management’s article does a great job of collecting the studies of interest for myopia. Pay close attention to article #20, The Projection of Glaucoma Burden Worldwide in 2060 with Myopia Surge.?Truly shocking forecast. https://lnkd.in/e5pvTUNJ #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #glaucoma
Sydnexis
制药业
Del Mar，California 1,312 位关注者
We focus on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.
关于我们
Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence over the last 30 years. Once considered a benign refractive condition, even at low levels, myopia is now associated with many serious ophthalmic co- morbidities. The greater myopia severity, the higher the risk of these ophthalmic co-morbidities later in life. Sydnexis was founded with the goal of developing a proprietary, stable, low-dose atropine eyedrop to treat myopia progression in children and minimize the risk of ocular co-morbidities. Formulation Matters! At Sydnexis, we have focused on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.
- 网站
-
https://www.sydnexis.com
Sydnexis的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Del Mar，California
- 类型
- 私人持股
- 创立
- 2014
地点
-
获取路线
445 Marine View Ave Ste 295
US，California，Del Mar，Null
Sydnexis员工
动态
-
EXCITING NEWS: Sydnexis Announces FDA Acceptance of New Drug Application and PDUFA date for SYD-101, for the Treatment of Progression of Pediatric Myopia. Click the link below to view the full Press Release. https://lnkd.in/gfh7mZcW ?#myopia #myopiacontrol #myopiatreatment #ophthalmology #optometry #pediatrics #sydnexis #eyecare #futurevision
-
-
Do Not wait to begin myopia treatment. Start to treat myopia as soon as possible. #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision #visionimpairment
-
-
The earlier the better, is a key factor in treatment success of pediatric myopia patients. #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision #visionimpairment
-
-
Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050. https://lnkd.in/dy3ybvEh #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision #visionimpairment
-
Discover the dynamic individuals who power Sydnexis forward. Today we spotlight Erin Horn. Click here to watch the video! https://lnkd.in/gwB3iZj8
-
-
David Kading OD (The Myopia Podcast) and Patrick Johnson, President of Sydnexis discuss numerous topics including the formulation and stability of Sydnexis’s proprietary investigational drug for pediatric myopia progression. Podcast - https://lnkd.in/ghVTyAhb #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision #visionimpairment David Kading
-
-
Privately held, clinical-stage pharmaceutical company, Sydnexis Inc. has recently completed an evaluation of its patented low-dose atropine formulation, SYD-101, in a Pivotal Phase 3 clinical trial. Dwight Akerman, OD, MBA, Chief Medical Editor of Review of Myopia Management, interviewed Sydnexis CEO Perry Sternberg to learn more about the company and its therapeutic focus on the clinical development of ophthalmic treatments for disease states with limited treatment options. Article - https://lnkd.in/gThQ82dS #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision #visionimpairment
-
-
Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050. https://lnkd.in/dy3ybvEh #MyopiaAwareness #childhoodmyopia #myopia #myopiamanagement #myopiacontrol #optometry #optometrist #ophthalmology #ophthalmologist #myopicmaculopathy #EyeCare #FutureVision?#visionimpairment